ABIOMED (NASDAQ:ABMD) reported Q3 2018 earnings this Morning, coming in at $0.70 per share, beating Wall Street’s estimates of $0.50 per Share. Revenue for the quarter came in at $154.00 million in-line expectations of $154.00 million Recent Insider Trading for ABIOMED (NASDAQ:ABMD)
- On 10/30/2017 Dorothy E Puhy, Director, sold 6,364 with an average share price of $179.08 per share and the total transaction amounting to $1,139,665.12.
- On 10/30/2017 Michael G Howley, VP, sold 10,000 with an average share price of $178.64 per share and the total transaction amounting to $1,786,400.00.
- On 10/2/2017 Andrew J Greenfield, VP, sold 11,282 with an average share price of $169.32 per share and the total transaction amounting to $1,910,268.24.
- On 8/30/2017 Eric A Md Rose, Director, sold 982 with an average share price of $145.17 per share and the total transaction amounting to $142,556.94.
- On 8/24/2017 Eric A Md Rose, Director, sold 23,018 with an average share price of $151.09 per share and the total transaction amounting to $3,477,789.62.
- On 8/15/2017 Paul Thomas, Director, sold 10,000 with an average share price of $154.71 per share and the total transaction amounting to $1,547,100.00.
Recent Trading for ABIOMED (NASDAQ:ABMD) Shares of ABIOMED closed the previous trading session at with 4909 shares trading hands.